CCND1 and prostate carcinoma: Immunohistochemistry experiments revealed a low expression of cyclin D1, c-myc, and c-jun in normal prostate tissues, and an upregulation of cyclin D1, c-myc, and c-jun in prostate carcinoma tissues (Figure 4A).